Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 30, 2023
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
[ Mon, Oct 30th 2023
] - WOPRAI
Serge Belanger Maintained (VRDN) at Strong Buy with Decreased Target to $30 on, Oct 30th, 2023
Serge Belanger of Needham, Maintained "Viridian Therapeutics, Inc." (VRDN) at Strong Buy with Decreased Target from $40 to $30 on, Oct 30th, 2023.
Serge has made no other calls on VRDN in the last 4 months.
There are 6 other peers that have a rating on VRDN. Out of the 6 peers that are also analyzing VRDN, 0 agree with Serge's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Serge
- Alex Thompson of "Stifel" Reiterated at Strong Buy and Held Target at $40 on, Wednesday, September 13th, 2023
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $46 on, Wednesday, September 13th, 2023
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $37 on, Thursday, August 10th, 2023
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $44 on, Wednesday, August 9th, 2023
- Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $42 on, Wednesday, August 9th, 2023
- Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Wednesday, August 9th, 2023
